...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Oh how could I forget. For the costs, in addition to the ones I've pointed in the previous post you would also have to add in the $6 million loan to Hepalink plus 2 years of unpaid interest which I think is in US$ and whatever we owe Eversana. 

That $40 million KK2 is taliking about may be in the distant rear view mirror.

tada 

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply